Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Orange SA | 3.98% | $5.21M | $45.58B | 62.67% | 63 Neutral | |
| GlaxoSmithKline | 3.81% | $4.99M | $98.09B | 44.24% | 77 Outperform | |
| Reckitt Benckiser Group | 3.80% | $4.98M | $55.01B | 33.78% | 78 Outperform | |
| Enel SpA Unsponsored ADR | 3.78% | $4.95M | $110.87B | 47.94% | 71 Outperform | |
| BNP Paribas | 3.72% | $4.87M | $111.81B | 57.72% | 72 Outperform | |
| TSMC | 3.29% | $4.31M | $1.43T | 61.89% | 81 Outperform | |
| British American Tobacco | 3.17% | $4.15M | $125.72B | 60.38% | 59 Neutral | |
| Royal KPN | 3.05% | $3.99M | $16.87B | 22.53% | 68 Neutral | |
| Novo Nordisk | 3.04% | $3.98M | $268.01B | -20.79% | 73 Outperform | |
| UBS Group AG | 3.03% | $3.96M | $147.97B | 39.19% | ― |